Accolade to Announce Fiscal Second Quarter 2025 Financial Results

SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market open. In conjunction, the company will host a conference call to review results at 8:00 a.m. E.T. on the same day.

Conference Call Details

To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here (https://register.vevent.com/register/BI0b6b999c6e7b47fdb26d7e8a774df09f). Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN.

To Listen via Internet: The conference call can be accessed via a live audio webcast that will be available online at http://ir.accolade.com .

Replay: A replay of the call will be available for one year via webcast for on-demand listening shortly after the completion of the call, at http://ir.accolade.com.

About Accolade, Inc.

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedInTwitter, Instagram and Facebook.

Investor Contact:

Todd Friedman, Investor Relations, IR@accolade.com

Media Contact:

Media Inquiries, Media@accolade.com

Source: Accolade        

This press release was published by a CLEAR® Verified individual.

Staff

Recent Posts

MIT xPRO Launches the Medical Technology Program for Global Leaders in Collaboration with Emeritus

This seven-month online program is designed to help senior medtech executives step up to a…

52 mins ago

Neurohacker Announces Name Change To Qualia Life Sciences As Part Of Expansion

CARLSBAD, Calif., Sept. 18, 2024 /PRNewswire/ -- The pioneering health and wellness brand formerly known…

52 mins ago

Nanocoatings Market Surges to USD 20.4 Billion by 2030, Propelled by 6.9% CAGR – Verified Market Reports®

The Nanocoatings market is driven by increasing demand across industries like automotive, electronics, and healthcare,…

52 mins ago

Live Cell Imaging Market Surges to USD 4.42 Billion by 2030, Propelled by 7.52% CAGR – Verified Market Reports®

The live cell imaging market is driven by advancements in cell biology research, increasing demand…

52 mins ago

Healthee Announces Enhanced App Set to Launch in Early 2025: A New Era of Effortless Benefits Navigation

NEW YORK, Sept. 18, 2024 /PRNewswire/ -- Healthee, a pioneer in health benefits technology, is…

52 mins ago

Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen’s Lawsuit

IRVINE, Calif., Sept. 18, 2024 /PRNewswire/ -- Zymo Research Corporation, a leader in innovative life…

52 mins ago